Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Chichester, West Sussex, United Kingdom : John Wiley & Sons Limited,
Erscheinungsjahr
2015
Beschreibungen/Notizen
Description based upon print version of record.
Includes bibliographical references and index.
Urgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization
Biomarkers of plaque rupture Biomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infrared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins
Antithrombin agents Factor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References
Chapter 7 Anticoagulant Management of Heparin-Compromised Patients Introduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction
Percutaneous coronary intervention New anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References
Chapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments
Illustrating the differences between urgent interventions and interventions performed to manage chronic conditions the authors present the chapters in a consistent template for ease of use covering; background, indications, evidence review, device description, procedural techniques, follow-up care, and complications. Shows the differences between interventions performed to manage chronic conditions and interventions that are truly urgent Chapters follow a consistent structure from background through indications, evidence review, device description, procedural techniques to follow-up care and